Combined therapy for hypopharyngeal cancer

Area of Science:

• Oncology
• Radiation Oncology
• Surgical Oncology

Background:

• Hypopharyngeal cancer presents a significant treatment challenge.
• Treatment strategies aim to balance oncologic outcomes with functional preservation.
• Previous studies reported varying survival rates based on treatment modalities.

Purpose of the Study:

• To evaluate the efficacy of different treatment strategies for hypopharyngeal cancer.
• To compare survival rates between preoperative radiotherapy followed by surgery and radical radiotherapy.
• To assess the impact of treatment selection on vocal function preservation.

Main Methods:

• Retrospective analysis of 69 hypopharyngeal cancer patients treated between 1979 and 1992.
• Comparison of outcomes for patients receiving preoperative radiotherapy and surgery versus radical radiotherapy.
• Analysis of survival rates stratified by cancer stage and treatment modality.

Main Results:

• The overall 5-year survival rate was 53%.
• Stage-specific survival rates ranged from 47% (Stage IV) to 80% (Stage I).
• Preoperative radiotherapy followed by surgery yielded a 59% 5-year survival rate.
• Radical radiotherapy as the primary treatment resulted in a 48% 5-year survival rate, with a recommendation for vocal function preservation.
• Salvage surgery for radiation failures had a 36% survival rate, while non-surgical management achieved 61% survival.

Conclusions:

• Radical radiotherapy is recommended as a first-choice treatment for hypopharyngeal cancer, prioritizing vocal function.
• Both studied treatment regimens demonstrated improved survival rates compared to historical data.
• Proper treatment selection, considering immune response and minimizing neck node metastasis, contributed to enhanced outcomes.